Ebola: DRC imposes 21-day quarantine for travelers from affected areas, WHO launches clinical trial

The Congolese government has implemented a mandatory 21-day health monitoring period for all individuals arriving from areas affected by the Ebola virus. This measure, announced by Health Minister Roger Kamba on June 24, applies to both domestic and international travel and aims to strengthen the response to the ongoing epidemic in the Democratic Republic of Congo.

In parallel efforts, the World Health Organization (WHO) announced on June 24 the upcoming launch of a clinical trial in the DRC. This trial, set to begin the following week, will evaluate the efficacy of two potential treatments for the Ebola virus. The initiative comes as the disease continues to spread despite significant efforts by health authorities and international partners.

Diplomatic and regional responses are also underway. During a meeting in Kinshasa on June 23, Congolese President Félix Tshisekedi and Burundian President Évariste Ndayishimiye discussed the health situation. President Tshisekedi stressed the need for enhanced cooperation among African nations in addressing health emergencies. President Ndayishimiye advocated for a coordinated response focused on prevention, regional collaboration, and adherence to scientific recommendations.

The article also references a discussion panel featuring Dr. Dieudonné Mwamba, Director General of the National Institute of Public Health; Anne-Judith Ndombasi, an expert on gender-based violence and humanitarian leadership; and Gratien de Saint Nicolas Iracan, a national deputy. Their insights were part of a broader dialogue on the Ebola response in the DRC.